Glaxo transfer pricing under spotlight

The Lawyers Weekly

March 16, 2012

Transfer pricing practices by multinationals have come under Canada Revenue Agency’s (CRA) spotlight out of concern that they may be used inappropriately to shift profit to low-tax jurisdictions from high-tax regions. 

This article discusses the first Supreme Court of Canada case in this area, involving drug company GlaxoSmithKline Inc. 

First published in the March 16, 2012 edition of The Lawyers Weekly, this article is co-authored by Adrienne Woodyard and David Nathanson.

To read the article on-line, please click here.